Skip to main content
. 2023 Jul 27;8(8):e585–e599. doi: 10.1016/S2468-2667(23)00123-8

Table 4.

Age-standardised rate (95% UI) of YLDs with percentage changes between 1990 and 2010, 2010 and 2019, and 1990 and 2019 for the leading causes of diseases, disabilities, and injuries in Australia

YLD rank
YLDs per 100 000 population (95% UI)
Age-standardised percentage change in YLDs (95% UI)
1990 2010 2019 1990 2010 2019 1990–2010 2010–19 1990–2019
Lower back pain 1 1 1 1115·3 (784·1 to 1484·7) 1080·5 (763·6 to 1443·3) 986·6 (685·3 to 1334·1) −3·1% (−6·7 to 0·6) −8·7% (−14·8 to −2·8) −11·5% (−17·5 to −5·6)
Depressive disorders 2 2 2 799·5 (550·6 to 1084·7) 861·6 (586·2 to 1182·1) 798·7 (549·4 to 1128·5) 7·8% (0·1 to 15·9) −7·3% (−15·9 to 2·3) −0·1% (−7·9 to 7·8)
Other musculoskeletal disorders 5 3 3 525·7 (356·8 to 738·5) 622·8 (426·9 to 862·1) 639·5 (427·9 to 891·1) 18·5% (10·3 to 26·7) 2·7% (−6·9 to 12·2) 21·6% (10·9 to 32·4)
Falls 6 6 4 464·5 (315·3 to 662·1) 521·9 (359·5 to 737·5) 564·8 (390·6 to 799·8) 12·4% (9·8 to 14·9) 8·2% (6·6 to 9·8) 21·6% (19·2 to 24·2)
Anxiety disorders 4 5 5 548·4 (362·0 to 775·8) 536·7 (381·0 to 724·2) 555·3 (366·7 to 785·0) −2·1% (−18·7 to 19·1) 3·5% (−13·2 to 23·5) 1·3% (−5·4 to 9·1)
Headache disorders 3 4 6 550·3 (122·6 to 1188·8) 551·6 (123·3 to 1192·6) 551·5 (122·4 to 1178·5) 0·2% (−3·0 to 3·3) 0·0% (−2·7 to 3·1) 0·2% (−3·0 to 3·5)
Exposure to mechanical forces 8 7 7 445·7 (291·7 to 671·0) 407·9 (265·1 to 616·0) 419·4 (274·8 to 638·3) −8·5% (−9·9 to −6·8) 2·8% (1·4 to 4·2) −5·9% (−7·7 to −4·2)
Drug-use disorders 12 8 8 303·1 (209·7 to 409·4) 359·1 (251·9 to 476·2) 411·5 (288·3 to 547·0) 18·5% (2·6 to 37·5) 14·6% (1·8 to 29·3) 35·8% (19·9 to 55·6)
Age-related and other hearing loss 10 9 9 382·3 (265·9 to 542·8) 355·5 (245·1 to 511·4) 355·2 (240·5 to 508·3) −7·0% (−10·8 to −3·3) −0·1% (−5·0 to 5·4) −7·1% (−12·4 to −1·7)
Asthma 7 10 10 459·3 (305·7 to 657·3) 334·5 (217·1 to 491·3) 344·3 (217·4 to 519·0) −27·2% (−36·6 to −17·7) 2·9% (−11·1 to 16·4) −25·0% (−37·8 to −8·9)
Gynaecological diseases 11 11 11 332·3 (229·5 to 465·8) 331·1 (227·3 to 466·1) 327·9 (226·2 to 463·5) −0·4% (−3·5 to 3·2) −0·9% (−4·2 to 2·2) −1·3% (−4·6 to 2·1)
Diabetes 19 13 12 198·7 (133·5 to 275·5) 302·2 (202·3 to 426·4) 326·8 (216·3 to 460·7) 52·1% (36·9 to 69·2) 8·2% (−0·4 to 18·3) 64·5% (47·6 to 85·2)
Oral disorders 9 12 13 423·2 (272·3 to 618·0) 308·0 (192·7 to 461·7) 315·3 (193·6 to 482·2) −27·2% (−32·2 to −21·5) 2·4% (−9·2 to 15·6) −25·5% (−35·4 to −14·7)
Osteoarthritis 13 14 14 283·0 (143·0 to 565·8) 297·7 (152·2 to 590·2) 312·9 (158·4 to 634·0) 5·2% (−0·9 to 10·9) 5·1% (−0·1 to 11·3) 10·6% (6·9 to 14·5)
Schizophrenia 14 15 15 247·5 (186·9 to 298·1) 247·2 (186·8 to 300·3) 247·2 (187·5 to 300·3) −0·1% (−7·1 to 7·0) 0·0% (−5·7 to 6·3) −0·1% (−6·3 to 6·0)
Bipolar disorder 15 16 16 239·8 (145·4 to 363·5) 241·8 (147·5 to 370·1) 242·1 (146·1 to 370·2) 0·8% (−5·6 to 7·5) 0·1% (−4·2 to 4·6) 1·0% (−5·5 to 7·9)
Eating disorders 22 18 17 151·5 (93·5 to 228·8) 209·6 (136·6 to 295·8) 217·7 (142·6 to 307·4) 38·3% (17·0 to 67·5) 3·9% (−3·6 to 11·5) 43·7% (22·2 to 71·8)
Chronic obstructive pulmonary disease 16 17 18 225·3 (178·3 to 263·7) 222·6 (174·3 to 270·1) 201·1 (160·5 to 236·1) −1·2% (−12·7 to 14·0) −9·7% (−22·2 to 2·0) −10·7% (−15·2 to −6·3)
Endocrine, metabolic, blood, and immune disorders 18 19 19 202·5 (134·6 to 283·2) 201·3 (136·3 to 283·8) 200·3 (135·1 to 281·3) −0·6% (−5·6 to 4·4) −0·5% (−5·6 to 4·5) −1·1% (−5·8 to 3·7)
Other unintentional injuries 17 20 20 212·5 (135·4 to 317·2) 187·2 (119·4 to 280·3) 193·8 (123·5 to 290·1) −11·9% (−13·8 to −9·7) 3·5% (1·5 to 5·4) −8·8% (−10·6 to −6·8)
Alcohol use disorders 21 21 21 162·5 (107·5 to 233·6) 171·5 (113·2 to 241·5) 183·9 (121·5 to 259·4) 5·5% (−5·6 to 17·1) 7·2% (−2·5 to 17·9) 13·2% (1·4 to 26·2)
Neonatal disorders 20 22 22 179·6 (134·5 to 235·3) 163·0 (122·7 to 213·2) 158·1 (121·1 to 199·7) −9·2% (−24·8 to 10·2) −3·0% (−19·7 to 16·9) −12·0% (−27·4 to 7·7)
Other mental disorders 25 23 23 140·9 (93·4 to 201·2) 140·9 (93·3 to 200·5) 140·7 (93·9 to 200·1) 0·0% (−4·4 to 4·5) −0·2% (−4·3 to 4·3) −0·2% (−4·2 to 4·2)
Psoriasis 23 24 24 145·4 (103·1 to 191·9) 139·7 (99·8 to 185·3) 127·0 (90·1 to 167·3) −3·9% (−9·0 to 1·8) −9·1% (−14·4 to −3·9) −12·6% (−17·5 to −7·4)
Dermatitis 26 25 25 122·7 (68·1 to 205·4) 123·5 (69·1 to 202·0) 122·6 (68·3 to 201·8) −0·7% (−5·8 to 5·2) 0·7% (−4·8 to 7·2) 0·0% (−5·4 to 5·8)

Note that causes are ordered by their ranking in 2019. YLDs=years of life lived with disability. UI=uncertainty interval.